PLACE OF THIS DOCUMENT IN THE VIEN GUT DOSSIER

A.0 is the architectural statement for the whole Vien Gut academic dossier. It is not a disease-specific paper and it is not a step-by-step operating manual. Its job is to explain what problem this dossier is trying to solve, why the dossier was built, why the model uses four verification targets as its central reference points, and how the full dossier is organized from academic foundation to dialogue and validation.

To read A.0 in its proper place, it is necessary to understand the four layers of the dossier:

Layer 1 — Basic architecture (Parts A and B): Part A establishes the academic foundation: the central subject of the dossier, the WHAT–HOW–DATA-to-operate framework, the conceptual set, the global HOW gap, and the standardized terminology system. Part B describes the general outpatient operating model: the first clinic visit, the four-phase treatment plan, the conditions for the window of opportunity, the patient’s role, and enabling conditions. This layer applies across all disease axes.

Layer 2 — Application of the architecture to each specific disease axis (Part C): Each C document takes one disease axis as the main axis and presents how the A–B architecture is applied to the treatment of that axis together with its related comorbidities. In C.1, gout is the main axis; in subsequent documents, the kidney, cardiovascular, liver, or other disease axes may become the main axis, but all still operate on the same foundational architecture.

Layer 3 — Appendices (protocols and procedures): The appendix set contains specific protocols and procedures serving one or multiple disease axes simultaneously. This is the detailed implementation layer and the point of linkage across the C documents.

Layer 4 — Academic dialogue, evidence benchmarking, and the multicenter validation roadmap (Part D): Part D is where the Vien Gut Model moves from publication to technical dialogue, benchmark comparison with groups that have published corresponding targets, and stepwise progression toward multicenter validation along the roadmap for each target.

ABSTRACT

A.0 introduces the architecture of the Vien Gut academic dossier. The main subject is not gout alone. The real subject is a larger clinical problem: how to organize integrated outpatient care for people who live with complex chronic multimorbidity.

International guidelines already provide a strong WHAT layer: treatment targets, drugs, thresholds, and disease-specific recommendations. What is still missing in many real-world settings is the HOW layer – how care is organized across several diseases at the same time – and the DATA-to-operate layer – what longitudinal data are needed to make safe decisions over time.

The dossier uses four verification targets as its central clinical reference points: crystal-free status in gout, dialysis deferral in chronic kidney disease, prevention of heart failure decompensation, and hepatic recompensation in cirrhosis. These are not entirely new goals. They are goals that already have international evidence behind them. The Vien Gut Model uses them to test whether an integrated, personalized, longitudinal outpatient architecture can turn guideline WHAT into real results for people with complex chronic multimorbidity.